Inventor · disambiguated record
Chao Yu
Also filed as: YU CHAO · YU CHAO-WU
17 granted patents·11 pending applications·78 citations·filing 2013–2025
92Inventor score
Top patents by PatentIndex Score
28 records- 0198US9834545B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2016·Granted Dec 5, 2017·26 cites·33 claims
- 0297US9809581B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2016·Granted Nov 7, 2017·23 cites·29 claims
- 0394US10370363B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2017·Granted Aug 6, 2019·6 cites·13 claims
- 0494US10336736B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2017·Granted Jul 2, 2019·6 cites·24 claims
- 0591US10988464B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2019·Granted Apr 27, 2021·3 cites·16 claims
- 0690US11040960B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Jun 22, 2021·3 cites·14 claims
- 0789US10759789B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2019·Granted Sep 1, 2020·2 cites·27 claims
- 0889US10421748B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2018·Granted Sep 24, 2019·3 cites·43 claims
- 0986US11434230B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2020·Granted Sep 6, 2022·1 cites·14 claims
- 1083US12139475B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2022·Granted Nov 12, 2024·0 cites·4 claims
- 1177US9155739B2Histone deacetylases (HDACs) inhibitorsANNJI PHARM CO LTD·Filed 2015·Granted Oct 13, 2015·3 cites·20 claims
- 1275US11207294B2Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Dec 28, 2021·1 cites·6 claims
- 1374US11945805B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2021·Granted Apr 2, 2024·0 cites·9 claims
- 1473US11820759B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2021·Granted Nov 21, 2023·0 cites·8 claims
- 1571US11684606B2Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2CHEMOCENTRYX INC·Filed 2021·Granted Jun 27, 2023·0 cites·15 claims
- 1667US2025066372A1Heterocyclic compounds, compositions thereof, and methods of treatment therewithBEIGENE LTD·Filed 2024·Application pending·0 cites
- 1766US9387209B2Histone deacetylases (HDACs) inhibitorsANNJI PHARM CO LTD·Filed 2013·Granted Jul 12, 2016·1 cites·15 claims
- 1866US2025101028A1Heterocyclic compounds, compositions thereof, and methods of treatment therewithBEIGENE LTD·Filed 2024·Application pending·0 cites
- 1966US2024262848A1Heterocyclic compounds, compositions thereof, and methods of treatment therewithBEIGENE LTD·Filed 2024·Application pending·0 cites
- 2062US2017204087A12-oxindole compoundsCHEMOCENTRYX INC·Filed 2017·Application pending·0 cites
- 2155US2024140957A1Bridged compounds as kras g12d inhibitor and degrader and the use thereofBEIGENE SWITZERLAND GMBH·Filed 2022·Application pending·0 cites
- 2253US2024092803A1Bridged compounds as kras g12d inhibitor and degrader and the use thereofBEIGENE SWITZERLAND GMBH·Filed 2022·Application pending·0 cites
- 2348US2022389021A1Inhibitors of kras g12cBEIGENE LTD·Filed 2020·Application pending·0 cites
- 2448US2025262222A1Heterocyclic compounds, compositions thereof, and methods of treatment therewithBEIGENE SWITZERLAND GMBH·Filed 2025·Application pending·0 cites
- 2547US2025250287A1Heterocyclic compounds, compositions thereof, and methods of treatment therewithBEIGENE SWITZERLAND GMBH·Filed 2025·Application pending·0 cites
- 2646US2025221996A1Heterocyclic compounds, compositions thereof, and methods of treatment therewithBEIGENE LTD·Filed 2025·Application pending·0 cites
- 2740US2023212129A1Quinazoline derivatives useful as selective hdac6 inhibitorsANNJI PHARM CO LTD·Filed 2021·Application pending·0 cites
- 2836US11535598B2Histone deacetylases (HDACs) inhibitorsANNJI PHARM CO LTD·Filed 2018·Granted Dec 27, 2022·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Chao Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →